Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy

Thor A. Wagner; Camlin Tierney; Sharon Huang; Sharon Nichols; Kathleen Malee; Nicole A. Montañez; Anne Coletti; Hans Spiegel; Chelsea Krotje; Frederic Bone; Megan Wilkins; Lisa Abuogi; Murli Purswani; Allison Bearden; Andrew Wiznia; Allison Agwu; Ellen G. Chadwick; Douglas D. Richman; Monica Gandhi; Patrick Mehta; Bernard Macatangay; Stephen A. Spector; Serena Spudich; Deborah Persaud; Ann Chahroudi

doi:10.1097/qad.0000000000003937

Abstract

Central nervous system (CNS) HIV infection can impact cognition and may be an obstacle to cure in adolescents and young adults with perinatal HIV (AYAPHIV). IMPAACT2015 enrolled AYAPHIV on suppressive antiretroviral therapy (ART) with cognitive impairment to detect and quantify HIV in blood and cerebrospinal fluid (CSF).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wagner et al. (2024) studied this question.

synapsesocial.com/papers/68e67a9ab6db643587604b2a https://doi.org/10.1097/qad.0000000000003937

View Full Paper

Ask AI

Bookmark

Share

Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy

Abstract

Discussion

Cite This Study

Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy

Abstract

Discussion

Cite This Study

Keep reading

Keep reading